These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 3905378)

  • 1. Development of quantitative structure-pharmacokinetic relationships.
    Mayer JM; van de Waterbeemd H
    Environ Health Perspect; 1985 Sep; 61():295-306. PubMed ID: 3905378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative structure-pharmacokinetic relationships and drug design.
    Seydel JK; Schaper KJ
    Pharmacol Ther; 1981; 15(2):131-82. PubMed ID: 6124012
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative structure-pharmacokinetics relationships and their importance in drug design, possibilities and limitations.
    Seydel JK
    Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):571-81. PubMed ID: 6513673
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro, in silico and integrated strategies for the estimation of plasma protein binding. A review.
    Lambrinidis G; Vallianatou T; Tsantili-Kakoulidou A
    Adv Drug Deliv Rev; 2015 Jun; 86():27-45. PubMed ID: 25819487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to identify compounds posing problems in absorption, distribution and elimination.
    Schmid K
    Arch Toxicol Suppl; 1985; 8():196-204. PubMed ID: 3868349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictions of the ADMET properties of candidate drug molecules utilizing different QSAR/QSPR modelling approaches.
    Khan MT
    Curr Drug Metab; 2010 May; 11(4):285-95. PubMed ID: 20450477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships and drug disposition.
    Lien EJ
    Annu Rev Pharmacol Toxicol; 1981; 21():31-61. PubMed ID: 7016008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based absorption, distribution, metabolism, excretion (ADME) and its interplay with alternative toxicity methods.
    Tsaioun K; Blaauboer BJ; Hartung T
    ALTEX; 2016; 33(4):343-358. PubMed ID: 27806179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of pharmacokinetic principles in practice.
    Ramsey JC; Gehring PJ
    Fed Proc; 1980 Jan; 39(1):60-5. PubMed ID: 7351245
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative structure--plasma protein binding relationships of acidic drugs.
    Zhivkova Z; Doytchinova I
    J Pharm Sci; 2012 Dec; 101(12):4627-41. PubMed ID: 22961754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal clearance and volume of distribution of compounds in rabbits: In silico prediction and pharmacokinetic simulations for drug development.
    del Amo EM; Vellonen KS; Kidron H; Urtti A
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):215-26. PubMed ID: 25603198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput and in silico techniques in drug metabolism and pharmacokinetics.
    van de Waterbeemd H
    Curr Opin Drug Discov Devel; 2002 Jan; 5(1):33-43. PubMed ID: 11865671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How experimental errors influence drug metabolism and pharmacokinetic QSAR/QSPR models.
    Wenlock MC; Carlsson LA
    J Chem Inf Model; 2015 Jan; 55(1):125-34. PubMed ID: 25406036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic approaches to the study of drug interactions.
    Levy G
    Ann N Y Acad Sci; 1976; 281():24-39. PubMed ID: 798525
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges.
    Masimirembwa CM; Bredberg U; Andersson TB
    Clin Pharmacokinet; 2003; 42(6):515-28. PubMed ID: 12793837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico ADME prediction: data, models, facts and myths.
    Lombardo F; Gifford E; Shalaeva MY
    Mini Rev Med Chem; 2003 Dec; 3(8):861-75. PubMed ID: 14529504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Distribution Part 2. Predicting Volume of Distribution from Plasma Protein Binding and Membrane Partitioning.
    Korzekwa K; Nagar S
    Pharm Res; 2017 Mar; 34(3):544-551. PubMed ID: 27966088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting binding affinities of diverse pharmaceutical chemicals to human serum plasma proteins using QSPR modelling approaches.
    Basant N; Gupta S; Singh KP
    SAR QSAR Environ Res; 2016; 27(1):67-85. PubMed ID: 26854728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered disposition of drugs in acute renal failure rat models: drug development strategies and perspectives.
    Srinivas NR
    Arzneimittelforschung; 2010; 60(12):731-48. PubMed ID: 21265465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-pharmacokinetic relationship of in vivo rat biliary excretion.
    Chen Y; Cameron K; Guzman-Perez A; Perry D; Li D; Gao H
    Biopharm Drug Dispos; 2010 Jan; 31(1):82-90. PubMed ID: 19908216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.